← FDA Drug Approvals (Drugs@FDA)

ADRENALIN

NDA · New Drug Application · Sponsor: PH HEALTH · Approved 2023-04-21

Drug application

FDA Application #

NDA215875

Application type

New Drug Application

Brand name

ADRENALIN

Generic name

EPINEPHRINE IN SODIUM CHLORIDE

Active ingredients

EPINEPHRINE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PH HEALTH

Manufacturer

Par Health USA, LLC

First approval

2023-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown